Trademark: 79247187
Word
RYLANAX
Status
Dead
Status Code
404
Status Date
Thursday, February 10, 2022
Serial Number
79247187
Registration Number
5760081
Registration Date
Tuesday, May 28, 2019
Mark Type
4000
Filing Date
Wednesday, September 26, 2018
Published for Opposition
Tuesday, March 12, 2019
Cancellation Date
Thursday, February 10, 2022

Trademark Owner History
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The wording "RYLANAX" has no meaning in a foreign language.

Trademark Events
Sep 3, 2022
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Sep 3, 2022
Death Of International Registration
Oct 4, 2019
Final Decision Transaction Processed By Ib
Sep 13, 2019
Final Disposition Notice Sent To Ib
Sep 13, 2019
Final Disposition Processed
Aug 28, 2019
Final Disposition Notice Created, To Be Sent To Ib
May 28, 2019
Registered-Principal Register
Mar 12, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2019
Published For Opposition
Mar 8, 2019
Notification Processed By Ib
Feb 20, 2019
Notification Of Possible Opposition Sent To Ib
Feb 20, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 20, 2019
Notification Of Notice Of Publication E-Mailed
Feb 5, 2019
Law Office Publication Review Completed
Feb 4, 2019
Approved For Pub - Principal Register
Feb 2, 2019
Teas/Email Correspondence Entered
Feb 2, 2019
Correspondence Received In Law Office
Feb 2, 2019
Assigned To Lie
Feb 1, 2019
Refusal Processed By Ib
Jan 29, 2019
Teas Response To Office Action Received
Jan 23, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 23, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 12, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Jan 12, 2019
Refusal Processed By Mpu
Jan 1, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Dec 31, 2018
Non-Final Action Written
Dec 31, 2018
Assigned To Examiner
Dec 18, 2018
Application Filing Receipt Mailed
Dec 14, 2018
New Application Office Supplied Data Entered In Tram
Dec 7, 2018
Limitation From Original Application Entered
Dec 6, 2018
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24